4 During 1977During -1978 patients with severe head injury were admitted and underwent intracranial pressure (ICP) monitoring. All patients had Glasgow Coma Scale (GCS) scores of 7 or less. All received identical initial treatment according to a standardized protocol. The patients' average age was 29 years; 60% had multiple trauma, and 35% needed emergency intracranial operations. Treatment for elevations of ICP was begun when ICP rose to 20 to 25 mm Hg, and included mannitol therapy and drainage of cerebrospinal fluid (CSF) when possible. Forty-three patients (34%) had ICP greater than or equal to 25 mm Hg; of these, 36 (84%) died. The mortality rate of the entire group was 46%.
I
NTRACRANIAL pressure (ICP) monitoring has become widely used in clinical neurosurgery since Lundberg's classic report in 1960. 9 Its application to the management of head injury has yielded much information about the pathophysiology and clinical epiphenomena of acute head injury. Miller, et al., 11, 12 have documented that patients who have uncontrolled ICP levels greater than 20 mm Hg have a mortality rate of 92% to 100%. Byrnes and Ducker ~ reported a mortality rate of 84% in patients whose ICP was greater than 25 mm Hg. Many other investigators have presented large series of head injuries managed according to protocols calling for ICP monitoring and medical management of raised ICP? -s.l~
Two facts have become apparent in this field: 1) levels of ICP between 20 and 30 mm Hg (if uncontrolled) are associated with extremely high and unacceptable mortality rates; and 2) ICP monitoring and aggressive medical management of elevated ICP may improve the morbidity and mortality rates of patients with severe head injury. Bowers and MarshalP have demonstrated a difference in the mortality rates of patients with Glasgow Coma Scale (GCS) scores of 3 to 5 in whom ICP was monitored (39%) compared to those who were not monitored (62%). Yet, from a practical clinical application, there is a dearth of statistically significant documentation that aggressive medical and surgical management of raised ICP does indeed alter mortality and outcome in this patient population.
The purpose of this report is twofold: 1) to describe our present management protocol for severe head injuries and to review our latest series of patients, and 2) to compare the results of this present series to our previous series of patients. Both series are clinically similar (as will be seen later), treated at the same institution, with the same management protocol with the exception of the approach to the treatment of elevated ICP.
Clinical Material and Methods
All patients in both series were admitted to the Maryland Institute for Emergency Medical Services Systems Shock-Trauma Unit. This is a statewide multiple trauma and neurotrauma referral center. The majority (80%) of the patients are delivered by helicopter directly from the accident scene and arrive within 30 to 60 minutes after injury. Patients were excluded from this study if they: did not undergo ICP monitoring, died within 24 hours, or sustained gunshot wounds to the head.
Series 1
The first series (Series I) consisted of patients admitted during 1977 and 1978, as previously reported by Byrnes and Ducker 6 ( Table 1) . There were 127 patients with severe head injuries who had GCS scores of 7 or less. They all underwent ICP monitoring with either an intraventricular catheter or subarachnoid screw. There were 96 males and 31 females. The ages ranged from 14 to 66 years, with an average of 29 years. Sixty percent of the patients had multiple trauma (defined as an associated chest injury, abdominal injury requiring surgery, major fracture of one or more extremities, or spinal injury), and 32% had intracranial mass lesions that needed emergency surgery. Every patient received the same initial treatment protocol, which included immediate neurological evaluation, intubation and hyperventilation, steroid therapy, computerized tomography (CT) scan and/or angiography for diagnosing mass lesions, immediate surgery for mass lesions causing midline shift, and intensive nursing care. In this series, treatment for elevations of ICP was begun when ICP reached 20 to 25 mm Hg. The treatment included mannitol therapy and drainage of cerebrospinal fluid (CSF) when possible. This treatment was not administered according to a strict protocol.
Series H
In 1979, we instituted a very strict ICP treatment protocol which is part of a controlled randomized barbiturate therapy study. Patients in this series (Series II) were admitted during the year 1979-1980 ( Table 1 ). The series consisted of 106 patients, all of whom underwent ICP monitoring and had a GCS score of 7 or less. There were 80 males and 26 females. The ages ranged from 14 to 81 years, with an average of 29 years. Fifty-six percent had multiple trauma, and 31% underwent emergency operations for mass lesions. All of the patients were treated according to the same standardized protocol as outlined for Series I with the exception of the specific treatment of elevated ICP. In Series II, if ICP was 15 mm Hg or less, the patients were continued on hyperventilation for 2 days; steroids were continued for 3 days and then the patient's clinical response was the determining factor for continuation of steroids; TM intensive care nursing was continued. If, however, ICP reached 16 mm Hg for longer than 10 minutes with the patient at rest, the above-mentioned treatment was continued and, in addition, mannitol was begun. Doses of 12.5 to 25 gm every 4 to 6 hours were employed. Occasionally, continuous marmitol infusion was initiated. If ICP persisted in the 16 to 24 mm Hg range, CSF was drained to gain control of the ICP. If ICP reached 25 mm Hg for 10 minutes at rest, the patients were randomized into the controlled barbiturate study. If they were randomized into the "no barbiturate" group, they were continued on the same regimen as those with ICP of 16 to 24 mm Hg. If they were randomized into the "barbiturate" group, they were continued on the existing therapy, and high-dose pentobarbital therapy was begun. A loading dose of 10 mg/kg/hr was administered intravenously for 4 consecutive hours. After this 4-hour loading dose, a continuous maintenance infusion of 1.6 mg/kg/hr was administered. If ICP came under control, the CSF drainage and mannitol infusion were gradually stopped. As noted above, the only difference between this regimen and that of Series I is the fact that ICP elevations are treated earlier (that is, at levels greater than 15 mm Hg rather than 20 to 25 mm Hg) and the treatment is administered according to a strict protocol.
Results
Of the 127 patients in Series I, 43 (34%) had ICP levels of 25 mm Hg or greater and 36 of these 43 died, for a mortality rate of 84% (Table 2 ). Eighty-four had ICP's under 25 mm Hg and 22 (26%) died. The overall mortality of the entire series was 46% at 3 months after injury.
In Series II, 26 of the 106 patients (25%) had ICP levels of 25 mm Hg or greater and 18 (69%) of these died (Table 2) . Eighty patients had ICP's of less than 25 mm Hg and 12 (15%) died. The overall mortality rate at 3 months postinjury for this series was 28%.
Comparison of Series I and 11
The clinical features of these two series are strikingly similar (Table 1) , which is a reflection of the fact that, over the past 4 years, the patient population and the means of delivery of the patients to the ShockTrauma Unit has not changed. The average age was 29 years for both groups. However, of greater significance is the fact that the distribution of the ages in the various decades of life are quite comparable in both series (Fig. 1) . The incidence of multiple trauma was 60% and 56% for Series I and II, respectively. Furthermore, the degree of trauma was virtually the same, with 25% of both series having two or more additional body systems injured. The incidence of intracranial mass lesions necessitating surgery was 32% in Series I and 31% in Series II. As stated above, all patients in both series had GCS scores of 7 or less. Just as the distribution of the ages is significant, the distribution of the GCS scores should be comparable in both series. Figure 2 illustrates that distribution. It can be seen that the number of patients scoring 3 to 5 and those scoring 6 and 7 are very comparable in both of the series.
When we compare the results of these two series, some significant differences are demonstrated. In Series I, 43 of the total 127 patients (34%) had ICP's of 
Analysis of Series 11
Thirty-three patients in our present series required emergency intracranial surgery for the following reasons: depressed skull fractures in four; intracerebral hematomas in three; focal lobar swelling in six; epidural hematomas in six; and subdural hematomas in 14. Thirty percent of those patients died; 27% were severely disabled or vegetative; 21% were moderately disabled; and 21% made a good recovery. These outcomes are based on the Glasgow Outcome Scale of Jennett and Bond s and were determined at 3 months after injury. They can be compared to the 3-month outcomes for the entire series discussed below and shown in Table 5 . Table 3 shows the relationship between the GCS score and the mortality rate. As might be expected, the worse the GCS score, the higher the mortality rate, which included nine (75%) of the 12 patients with a GCS score of 3; nine (39%) of the 23 with a score of 4; three (33%) of the nine with a score of 5; one (6%) of the 17 with a score of 6; and eight (16%) of the 45 with a score of 7.
In general, those patients with GCS scores of 5 to 7 died as a direct result of their multiple injuries and/ or sepsis. Those patients with scores of 3 and 4 died primarily as a result of their head injury, with high ICP. More specifically (Table 4) , of the 12 patients who died with GCS scores of 5 to 7, nine died from sepsis and multiple injuries and three due to their head injury. Of the 18 patients who died with GCS scores of 3 and 4, 13 died from their head injury and five died as a direct result of sepsis and multiple injuries. Therefore, of the 30 deaths in Series II, 14 were due to associated injuries and 16 were due to the head injury itself. Sepsis was a major factor in eight (27%) fatal cases. It should also be noted that 20 deaths occurred within the 1 st week of hospitalization. 
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Outcomes for Entire Series
We examined the outcomes for Series II at 3 and 6 months after trauma, based on Jennett and Bond's Glasgow Outcome Scale s (Table 5) . At 3 months, the outcomes were as follows: good recovery 20%; moderate disability 30%; severe disability 17%; vegetative state 5%; and dead 28%. At 6 months, we found the following outcomes: good recovery 48%; moderate disability 6%; severe disability 10%; vegetative state 3%; and dead 33%. The movement of patients within these groups over the 3-month interval is not surprising and confirms the importance of a 6-month outcome evaluation in head-injury studies.
Discussion
The factors that affect morbidity and mortality of patients with severe head injury were almost identical in both of these series. Both series were treated within the same emergency medical system, at the same hospital, with the same initial assessment and protocol. The only major difference was that in Series II, ICP elevations were treated earlier, more aggressively, and according to a strict protocol based on the level of ICP. This resulted in several major differences in the results of the two series. First, the number of patients whose ICP reached life-threatening levels (25 mm Hg or greater) was drastically reduced. As stated above, somewhere between 20 and 25 mm Hg of uncontrolled ICP is the "kiss of death" for the headinjured patient. A therapeutic regimen that reduces this phenomenon is, therefore, an advance over the previous regimen. Second, the mortality rate for these patients was also drastically reduced from 46% to 28%. Third, the new therapeutic regimen is not resulting in a disproportionate number of patients surviving in a severely disabled and vegetative state. The 6-month outcomes shown in Table 5 are certainly comparable to those of other series reported in the literature. 3, 12 The concept of early, aggressive treatment of elevated ICP is not new. Indeed, this has been stressed regularly in the literature by the investigators already cited. Moreover, the outcomes of our Series II compare most favorably to the other investigations employing similar protocols. What, then, is the significance of this paper? We have shown that within one head injury center, the adoption of a strict ICP treatment protocol based on continuous ICP monitoring T. G. Saul and T. B. Ducker data results in statistically significant better results for this patient population. It is our hope that such documentation will strengthen the argument for routine ICP monitoring of the severely brain-injured patient. Such a protocol demands that the treatment team know what the ICP is all of the time. Continuous ICP monitoring gives constant data with which one can make decisions about what therapeutic modalities to use and when to begin or discontinue these modalities. Furthermore, with continuous ICP monitoring, the intracranial consequence of all therapeutic modalities (including PEEP, fluid challenge, chest physiotherapy, and anesthesia) can also be assessed and adjusted to protect against secondary brain injury.
An argument may be made that we have not shown the efficacy of ICP monitoring because both series underwent ICP monitoring. For the purist, this may be true. However, consider the following: 1) uncontrolled elevations of ICP kill patients and hinder outcomes; 2) to treat elevated ICP aggressively at the appropriate levels, one should know what those levels are: otherwise, one may be treating people who do not require specific intervention or not treating people who actually do; and 3) the only sure way of knowing the ICP is through direct, continuous measurement. Clinical parameters (blood pressure, pulse, and respiratory and neurological status) are not always accurate indicators of ICP. Computerized tomography (CT) scanning does not correlate 100% with ICP. 1, 7 Miller, et al., 11 have shown that, in a majority of cases, when the CT scan is "normal," the ICP is not elevated. The question remains, however, as to whether the patient with a normal CT scan has raised ICP or normal ICP. Furthermore, Miller, et al., refrain from stating that these patients do not need ICP monitoring. They suggest that perhaps this group should undergo epidural monitoring, a less invasive procedure. It is our belief that, in order to properly institute this type of protocol which has a statistically significant beneficial effect, one must monitor ICP. However, ICP monitors, per se, do not save lives. The people who judiciously use the data obtained from ICP monitorhag can save lives and alter outcomes in patients with severe head injuries.
Conclusions
Based on the data presented here, we conclude that early, aggressive treatment of even mild ICP elevations prevents ICP from getting out of control and significantly reduces the number of patients with lifethreatening levels (25 mm Hg or greater). Severely head-injured patients benefit significantly from this early therapy for elevated ICP (based on ICP monitoting data) in that the mortality rate is reduced without causing a disproportionate number of severely disabled or vegetative patients.
